Showing results (61-70 of 70) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Cancer Medicine|September 5, 2023
Novel insight into histological and molecular astrocytoma, IDH-mutant, Grade 4 by the updated WHO classification of central nervous system tumorsWenlin Chen, Siying Guo, Yaning Wang, et al.Frontiers in Oncology|March 31, 2023
Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumorsXiaopeng Guo, Yixin Shi, Delin Liu, et al.Cancer Medicine|July 6, 2024
Clinical features, MRI, molecular alternations, and prognosis of astrocytoma based on WHO 2021 classification of central nervous system tumors: A single-center retrospective studyYuekun Wang, Hao Xing, Xiaopeng Guo, et al.Frontiers in Neuroscience|May 22, 2023
Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumorsWenlin Chen, Shanmu Jin, Qianshu Liu, et al.Discover Oncology|March 22, 2024
A prognostic model for overall survival in recurrent glioma patients treated with bevacizumab-containing therapyShanmu Jin, Wenlin Chen, Xiaopeng Guo, et al.Cancer Medicine|January 13, 2025
TERTp Mutation and its Prognostic Value in Glioma Patients Under the 2021 WHO Classification: A Real-World StudyHao Xing, Delin Liu, Junlin Li, et al.Frontiers in Oncology|July 24, 2023
Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumorsXiaopeng Guo, Lingui Gu, Yilin Li, et al.Frontiers in Neuroscience|April 10, 2024
Clinical roles of EGFR amplification in diffuse gliomas: a real-world study using the 2021 WHO classification of CNS tumorsHai Wang, Xin Zhang, Jiahui Liu, et al.BMC Neurology|June 14, 2024
The molecular signature and prognosis of glioma with preoperative intratumoral hemorrhage: a retrospective cohort analysisYixin Shi, Xiaoman Kang, Yulu Ge, et al.Journal of Molecular Neuroscience : MN|February 5, 2024
Molecular Determinants of Neurocognitive Deficits in Glioma: Based on 2021 WHO ClassificationKun Zhang, Tianrui Yang, Yu Xia, et al.Pageof 7